文献速递免疫规划慢病防控与筛查

血清IgG2水平预测SLE患者肺炎球菌疫苗接种长期保护

Serum IgG2 levels predict long-term protection following pneumococcal vaccination in systemic lupus erythematosus (SLE).
PubMed 文献 · Vaccine · 2020-09-04

仅10例在36个月时保持保护,52.4%无长期保护;基线血清IgG2>2.125 µg/ml预测长期保护的灵敏度100%、特异度90.9%。

要点

  • SLE患者序贯接种肺炎球菌疫苗后长期免疫保护率低。
  • 基线血清IgG2>2.125 µg/ml可识别能获益于接种的患者。
  • SLE疾病特征与治疗不影响长期保护,仅IgG2水平相关。

核心结论

  • SLE患者序贯接种PCV13/PPSV23后免疫保护较差,仅10例在36个月时仍具保护。
  • 基线血清IgG2水平>2.125 µg/ml对长期保护具有预测价值。

研究设计与样本

  • 在基线、2、6、12和36个月评估免疫保护,定义长期保护为至少70%的7种肺炎球菌血清型特异性IgG≥1.3 µg/mL。

主要发现

  • 保护组与未保护组的SLE疾病特征、治疗及免疫学特征无差异,仅接种前IgG2血清水平不同。
  • 血清IgG2>2.125 µg/ml预测长期保护的灵敏度为100%、特异度为90.9%。

关键数值与推荐

  • 免疫保护定义:抗原特异性IgG浓度≥1.3 µg/mL且覆盖至少70%的7种肺炎球菌血清型。
  • 血清IgG2>2.125 µg/ml作为长期保护的预测阈值,灵敏度100%、特异度90.9%。

临床怎么用

  • 对SLE患者接种肺炎球菌疫苗前可检测基线血清IgG2水平,>2.125 µg/ml者更可能获得长期保护。
  • 基线IgG2≤2.125 µg/ml的SLE患者序贯接种后长期保护可能不足,需考虑加强监测或免疫策略。

局限性

  • 仅评估7种肺炎球菌血清型,保护定义未涵盖所有血清型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Systemic lupus erythematosus (SLE) patients are at risk for pneumococcal infection. Twenty-one consecutive SLE patients (40[25-75] years) received the sequential PCV13/PPSV23 vaccine and factors associated with long-term protection were analyzed. Immune protection, defined by an antigen-specific IgG concentration ≥1.3 µg/mL for at least 70% of 7 pneumococcal serotypes was assessed at baseline, 2, 6, 12 and 36 months defining long-term protection. Only 10 patients showed pneumococcal immune protection 36 months after vaccination. Eleven (52.4%) patients had no long-term protection with a seroconversion that never or only transiently occurred. SLE disease features, treatment received and immunological characteristics did not differ between protected and unprotected patients except for the pre-vaccination IgG2 serum levels. Serum IgG2 level >2.125 µg/ml showed a sensitivity of 100% and a specificity of 90.9% for long-term protection. Sequential pneumococcal vaccination conferred poor immune protection in SLE. Baseline IgG2 serum level identified patients able to benefit from pneumococcal vaccination.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Gerard AL, Goulenok T, Bahuaud M, et al. Serum IgG2 levels predict long-term protection following pneumococcal vaccination in systemic lupus erythematosus (SLE). Vaccine. 2020. PMID: 32896468. doi:10.1016/j.vaccine.2020.08.065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。